Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ACCURUN™ 676 Cystic Fibrosis Extended Control
A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing, with assays that identify mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Supplier: SeraCare™ 20400009
Description
- Eliminates errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
- Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
- ACCURUN 676 covers 34 mutations, and when used in conjunction with ACCURUN 644, covers all 81 mutations in the Prima xTAG™ CFTR 70+6 Assay
- All mutations contained in a single vial
- High purity, large lots, stable materials–no additional processing required
Not for use in diagnostic procedures
Specifications
| RUO | |
| ACCURUN 676 Cystic Fibrosis Extended Control | |
| Detects significant errors with the use of rotating gDNA control schemes, research use only | |
| 100 μL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Product Content Correction